GHSI (Guardion Health Sciences) EBIT per Share : $-3.02 (TTM As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Guardion Health Sciences EBIT per Share?

Guardion Health Sciences's EBIT per Share for the three months ended in Jun. 2024 was $-1.07. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $-3.02.

During the past 3 years, the average EBIT per Share Growth Rate was 53.00% per year. During the past 5 years, the average EBIT per Share Growth Rate was 49.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Guardion Health Sciences's EBIT per Share or its related term are showing as below:

GHSI' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -13.1 Med: 30.65 Max: 55.3
Current: 53

During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of Guardion Health Sciences was 55.30% per year. The lowest was -13.10% per year. And the median was 30.65% per year.

GHSI's 3-Year EBIT Growth Rate is not ranked
in the Drug Manufacturers industry.
Industry Median: 8.15 vs GHSI: 53.00

Guardion Health Sciences's EBIT for the three months ended in Jun. 2024 was $-1.37 Mil.

Guardion Health Sciences EBIT per Share Historical Data

The historical data trend for Guardion Health Sciences's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guardion Health Sciences EBIT per Share Chart

Guardion Health Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-87.05

-30.05

-22.12

-6.53

-3.10

Guardion Health Sciences Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
EBIT per Share	Get a 7-Day Free Trial															-1.12	-0.61	-0.55	-0.80	-1.07

Guardion Health Sciences EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Guardion Health Sciences's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-3.942	/	1.271
=	-3.10

Guardion Health Sciences's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

	EBIT per Share		(Q: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.367	/	1.284
=	-1.06

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.02

Guardion Health Sciences (OTCPK:GHSI) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Guardion Health Sciences EBIT per Share Related Terms

Thank you for viewing the detailed overview of Guardion Health Sciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Guardion Health Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guardion Health Sciences Inc (OTCPK:GHSI) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

2925 Richmond Avenue, Suite 1200, Houston, TX, USA, 77098

Website

https://www.guardionhealth.com

Guardion Health Sciences Inc clinical nutrition company that develops and distributes clinically supported dietary supplements and medical foods. It offers a portfolio of science-based, clinically supported products designed to support consumers, healthcare professionals and providers, and their patients by supporting bone health, eye health, cardiovascular health, and brain health through nutrients such as Calcium, Vitamin D, Vitamin K, Carotenoids, and Omega-3s.

Executives

Bradley Louis Radoff	10 percent owner	2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098
Katharine Joan Cox	officer: Chief Accounting Officer	2925 RICHMOND AVENUE, SUITE 1200, HOUSTON TX 77098
Janet Hall	officer: CEO & President	2925 RICHMOND AVENUE, SUITE 1200, HOUSTON TX 77098
Family Foundation Radoff	other: See Footnote 1	2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098
Michaela Griggs	director	2925 RICHMOND AVENUE, SUITE 1200, HOUSTON TX 77098
Bret Scholtes	director, officer: Chief Executive Officer	2105 CITY WEST BLVD., SUITE 500, HOUSTON TX 77042
Donald A Gagliano	director	131 CARDINAL AVE, SAN ANTONIO TX 78209
Jeffrey S Benjamin	officer: Chief Accounting Officer	3885 CRESTWOOD PARKWAY, SUITE 550, DULUTH GA 30096
Craig Sheehan	officer: Chief Commercial Officer	15150 AVENUE OF SCIENCE, SUITE 200, SAN DIEGO CA 92128
Andrew C Schmidt	officer: Chief Financial Officer	1700 CARNEGIE AVE, SUITE 100, SANTA ANA CA 92705
Kelly Anderson	director	C/O TOMI ENVIRONMENTAL SOLUTIONS, INC., 9454 WILSHIRE BLVD., R-1, BEVERLY HILLS CA 90212
David W Evans	director, officer: Chief Scientific Officer	4141 JUTLAND DRIVE, SUITE 215, SAN DIEGO CA 92117
Tamara A Evans	10 percent owner	4141 JUTLAND DRIVE, SUITE 215, SAN DIEGO CA 92117
John Townsend	other: Controller	15150 AVENUE OF SCIENCE, SUITE 200, SAN DIEGO CA 92128
Gordon Bethwaite	officer: Vice Pres, Sales and Marketing	15150 AVENUE OF SCIENCE, SUITE 200, SAN DIEGO CA 92128